We use cookies on this site. By browsing our site you agree to our use of cookies. Close this message Find out more

Home > Biological Sciences > News, events and resources > Seminars > Cancelled - Dr Takis Athanasopoulos
More in this section Find out more

Cancelled - Dr Takis Athanasopoulos

10/01/2018 (15:00-16:00)
Molecular Image

Cell & Gene Therapy approaches at GlaxoSmithKline

Unfortunately this School Seminar is cancelled until further notice. If possible we will try to reschedule later this term.

Speaker: Dr Takis Athanasopoulos, Head of Transgene Delivery, GlaxoSmithKline (GSK), Medicines Research Centre

Cell & Gene Therapy approaches at GlaxoSmithKline: From Discovery Research to Manufacturing and Commercialisation

Gene therapy, genome editing and stem cells are areas of advance medical research in which we are increasingly seeing breakthroughs tacking a diversity of diseases, such as cancer, blindness, immune dysfunction, dementia and neurodegeneration, HIV/AIDS, heart and lung disease, skin disorders, and a plethora of inherited illnesses like haemophilia, cystic fibrosis, muscular dystrophy and immunodeficiency. Dr Athanasopoulos is an alumni PhD graduate of RHUL Bioscience, and now a Research Director in the gene therapy field at GSK (GlaxoSmithKline), a leading UK and global pharmaceutical company. He will provide insights and examples of the industrial processes from “bench to bedside” in the translation of gene and stem cell therapy into clinical practice, and the use of virus-like structures to deliver genetic material into patient cells.

Host: Prof George Dickson


Comment on this page

Did you find the information you were looking for? Is there a broken link or content that needs updating? Let us know so we can improve the page.

Note: If you need further information or have a question that cannot be satisfied by this page, please call our switchboard on +44 (0)1784 434455.

This window will close when you submit your comment.

Add Your Feedback